Thank you for making this conference a huge success!
The latest in the fast-moving journey—some call it a revolution—of biopharma development were well represented at the 2019 ISPE Biopharmaceutical Manufacturing Conference in Boston, MA on 18-20 June. The fourth annual conference drew more than 300 attendees, with 168 companies represented from 15 countries. They came together to learn about innovation in production methods and technologies that enable a competitive and sustainable biopharmaceutical product supply for the future—and the rapid changes that are bringing life-saving pharmaceuticals to patients in need.
The observation that this is “not your parents’ biopharma” was a theme of the three-day conference that addressed the latest developments in biopharma in plenary and concurrent breakout sessions. The next stage of the journey—into supply chain expansion and commercialization—highlighted the conference. Recent developments are being translated into therapies available to more patients, and keeping the patient in mind is most important for the industry, noted conference chair Andre Walker, CPIP, Principal, Walker BioPharm Consulting.